SARS-CoV-2 variant-dependent inflammasome activation-Reference-Cited by-同舟云学术

SARS-CoV-2 variant-dependent inflammasome activation

Published:2023-07 Issue:1 Volume:87 Page:62-63
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Teyssou Elisa,Marot Stéphane^ORCID,Gothland Adélie^ORCID,Malet Isabelle,Zafilaza Karen,Leducq Valentin,Cocherie Théophile,Todesco Eve^ORCID,Soulié Cathia,Marcelin Anne-Geneviève,Calvez Vincent

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference8 articles.

1. The high expression of key components of inflammasome and pyroptosis might lead to severe COVID‐19 infection in cancer patients;Cui;J Infect,2022

2. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients;Rodrigues;J Exp Med,2021

3. Inflammasome activation in infected macrophages drives COVID-19 pathology;Sefik;Nature,2022

4. Interleukin-1 as innate mediator of T cell immunity;Van Den Eeckhout;Front Immunol,2021

5. The choice of phorbol 12-myristate 13-acetate differentiation protocol influences the response of THP-1 macrophages to a pro-inflammatory stimulus. Elsevier Enhanced Reader〉; n.d. DOI: 〈10.1016/j.jim.2016.01.012.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction of the inflammasome by the SARS-CoV-2 accessory protein ORF9b, abrogated by small-molecule ORF9b homodimerization inhibitors;2024-06-03

2. SARS-CoV-2 virus-like particle variants alpha and delta mimic the native viruses in their differential inflammasome activating potential;Antiviral Research;2024-04